Guizhou Yibai Pharmaceutical Co., Ltd.
SHH: 600594.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ya Qi Dou
- Employees
- 5,509
- Headquarters
- Guiyang, China
- IPO year
- 2004
- Market cap
- CN¥3.3B
- Website
- https://www.gzcci.com
Loading 600594…
Loading profile data…Frequently asked questions about 600594
What does Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) do?
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism,...
Where does 600594.SS trade?
Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) trades on the Shanghai Stock Exchange.
What sector is 600594.SS in?
Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guizhou Yibai Pharmaceutical Co., Ltd.?
Ya Qi Dou is the chief executive officer of Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS).
Where is Guizhou Yibai Pharmaceutical Co., Ltd. headquartered?
Guizhou Yibai Pharmaceutical Co., Ltd. is headquartered in China.
Does 600594.SS pay a dividend?
Yes — Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) paid a trailing twelve-month dividend of CNY 0.07 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600594.SS go public?
Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) completed its initial public offering in 2004.